These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 5649572)

  • 21. Current good manufacturing practices for PET drug products in the United States.
    Swanson D; Graham M; Heinonen TM; Libby P; Mills GQ
    J Nucl Med; 2009 Aug; 50(8):26N-8N. PubMed ID: 19652213
    [No Abstract]   [Full Text] [Related]  

  • 22. [Medicines raw materials used in compounding medicines: an update of the legislation].
    Huyghebaert C; Leuckx S
    J Pharm Belg; 2010 Mar; (1):16-8. PubMed ID: 20429391
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of the analytical error on content uniformity sampling plans.
    Norberg R
    Pharm Acta Helv; 1972; 47(11):710-8. PubMed ID: 4657537
    [No Abstract]   [Full Text] [Related]  

  • 24. Disinfectants as an aid for good manufacturing practice in the pharmaceutical industry.
    Wallhäusser KH
    J Pharm Belg; 1981; 36(5):283-97. PubMed ID: 7310623
    [No Abstract]   [Full Text] [Related]  

  • 25. Characterization of the content uniformity plan.
    Sampson CB; Breunig HL; Comer JP; Broadlick DE
    J Pharm Sci; 1970 Nov; 59(11):1653-5. PubMed ID: 5495497
    [No Abstract]   [Full Text] [Related]  

  • 26. What is quality of medicines?
    Doogue MP; Thynne TR
    Intern Med J; 2013 Oct; 43(10):1057-8. PubMed ID: 24134167
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmaceutical controls for drug availability.
    Cook D
    Med Serv J Can; 1967 Mar; 23(3):323-36. PubMed ID: 6056376
    [No Abstract]   [Full Text] [Related]  

  • 28. [Guidelines for updating magistral recipes used in dentistry].
    Smid-Korbar J; Kristl J; Groselj D
    Zobozdrav Vestn; 1986; 41(5-6):101-4. PubMed ID: 3478907
    [No Abstract]   [Full Text] [Related]  

  • 29. [Progress in galenicals (1962-1964)].
    Chalabala M; Malý J; Zácek H
    Pharmazie; 1966 Feb; 21(2):73-95. PubMed ID: 4861050
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapeutic response in oral dosage forms.
    Morrison AB
    Med Serv J Can; 1967 Mar; 23(3):349-59. PubMed ID: 6056377
    [No Abstract]   [Full Text] [Related]  

  • 31. Errors discovered in a manufacturing program.
    Das Gupta V
    Am J Hosp Pharm; 1973 Feb; 30(2):112. PubMed ID: 4690464
    [No Abstract]   [Full Text] [Related]  

  • 32. Panel discussion: practical importance of generic equivalence.
    Ann Clin Res; 1974; 6(0):suppl 11:79-88. PubMed ID: 4212521
    [No Abstract]   [Full Text] [Related]  

  • 33. [Production and control in the pharmaceutical industry. Treatment of initial substances and materials. Organization and practice in larger plants].
    Büchler W
    Pharm Acta Helv; 1973 Jan; 48(1):11-21. PubMed ID: 4696261
    [No Abstract]   [Full Text] [Related]  

  • 34. [A simple method for the determination of the degree of fineness of tablet fragments after disintegration].
    Sanders JC
    Pharm Weekbl; 1969 Jun; 104(24):485-92. PubMed ID: 5791767
    [No Abstract]   [Full Text] [Related]  

  • 35. [Standards of acceptable manufacturing and inspection methods].
    Battaglino G
    Boll Chim Farm; 1984 Jun; 123(6):247-62. PubMed ID: 6497974
    [No Abstract]   [Full Text] [Related]  

  • 36. [Quality control in the pharmacy].
    Cohen EH
    Pharm Weekbl; 1968 Apr; 103(17):472-85. PubMed ID: 5665059
    [No Abstract]   [Full Text] [Related]  

  • 37. Adequate and sensible quality control.
    Schoulund B
    J Ir Med Assoc; 1968 Oct; ():Suppl 1:21. PubMed ID: 5701294
    [No Abstract]   [Full Text] [Related]  

  • 38. Panel discussion: biological indicators. Manufacture and quality control for a biological indicator.
    Day LM
    Bull Parenter Drug Assoc; 1971; 25(2):73-5. PubMed ID: 5563319
    [No Abstract]   [Full Text] [Related]  

  • 39. International Conference on Harmonisation; guidance on good manufacturing practice for active pharmaceutical ingredients; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Sep; 66(186):49028-9. PubMed ID: 12358036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response.
    Guharoy R; Noviasky J; Haydar Z; Fakih MG; Hartman C
    Chest; 2013 Aug; 144(2):717-718. PubMed ID: 23918133
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.